ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 226 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2018. The put-call ratio across all filers is 5.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,156,228 | +5.3% | 240,200 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $2,997,540 | -2.6% | 237,900 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $3,078,495 | -34.8% | 235,900 | -11.8% | 0.00% | -33.3% |
| Q4 2022 | $4,718,700 | +12.6% | 267,500 | -2.8% | 0.00% | 0.0% |
| Q3 2022 | $4,190,000 | +3.2% | 275,100 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $4,059,000 | -37.8% | 273,700 | -5.6% | 0.00% | -25.0% |
| Q1 2022 | $6,526,000 | +28.6% | 289,800 | +5.3% | 0.00% | +33.3% |
| Q4 2021 | $5,076,000 | +21.7% | 275,100 | -11.8% | 0.00% | 0.0% |
| Q3 2021 | $4,170,000 | -35.3% | 311,900 | -10.4% | 0.00% | -25.0% |
| Q2 2021 | $6,445,000 | +18.9% | 348,200 | -3.5% | 0.00% | 0.0% |
| Q1 2021 | $5,420,000 | +1.9% | 361,000 | -2.0% | 0.00% | 0.0% |
| Q4 2020 | $5,320,000 | +77.4% | 368,400 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $2,999,000 | +22.2% | 368,400 | +1.6% | 0.00% | 0.0% |
| Q2 2020 | $2,454,000 | +10.7% | 362,500 | +15.1% | 0.00% | 0.0% |
| Q1 2020 | $2,217,000 | -29.2% | 314,900 | -1.3% | 0.00% | -33.3% |
| Q4 2019 | $3,131,000 | -8.7% | 319,000 | +2.1% | 0.00% | -25.0% |
| Q3 2019 | $3,429,000 | -7.4% | 312,300 | -1.9% | 0.00% | 0.0% |
| Q2 2019 | $3,703,000 | +21.9% | 318,400 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $3,038,000 | +2.0% | 318,400 | +3.1% | 0.00% | -25.0% |
| Q4 2018 | $2,977,000 | -33.6% | 308,800 | -1.9% | 0.00% | -20.0% |
| Q3 2018 | $4,486,000 | +18.7% | 314,800 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $3,778,000 | +2.4% | 314,800 | +5.4% | 0.00% | 0.0% |
| Q1 2018 | $3,689,000 | -13.0% | 298,700 | +2.5% | 0.00% | -20.0% |
| Q4 2017 | $4,240,000 | +2.2% | 291,400 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $4,147,000 | +11.5% | 291,400 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $3,718,000 | +0.6% | 291,400 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $3,695,000 | +24.2% | 291,400 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $2,975,000 | -20.9% | 291,400 | +2.1% | 0.01% | -16.7% |
| Q3 2016 | $3,759,000 | -1.1% | 285,400 | -4.6% | 0.01% | 0.0% |
| Q2 2016 | $3,800,000 | +0.3% | 299,200 | +0.7% | 0.01% | -14.3% |
| Q1 2016 | $3,790,000 | +3.2% | 297,200 | +24.4% | 0.01% | -22.2% |
| Q4 2015 | $3,674,000 | +28.5% | 238,900 | +3.6% | 0.01% | +28.6% |
| Q3 2015 | $2,859,000 | +3.7% | 230,600 | +14.4% | 0.01% | 0.0% |
| Q2 2015 | $2,758,000 | +22.7% | 201,600 | +7.3% | 0.01% | +16.7% |
| Q1 2015 | $2,247,000 | -5.2% | 187,900 | +1.2% | 0.01% | -33.3% |
| Q4 2014 | $2,371,000 | -2.3% | 185,700 | +2.6% | 0.01% | 0.0% |
| Q3 2014 | $2,428,000 | -17.8% | 181,000 | -1.6% | 0.01% | -18.2% |
| Q2 2014 | $2,952,000 | -7.4% | 183,900 | +4.0% | 0.01% | -15.4% |
| Q1 2014 | $3,188,000 | +50.7% | 176,800 | +29.2% | 0.01% | +62.5% |
| Q4 2013 | $2,115,000 | +4.7% | 136,800 | +0.7% | 0.01% | 0.0% |
| Q3 2013 | $2,021,000 | +11.4% | 135,900 | -3.1% | 0.01% | 0.0% |
| Q2 2013 | $1,814,000 | – | 140,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |